IE 11 is not supported. For an optimal experience visit our site on another browser.

Complete Genomics Schedules First Quarter 2011 Earnings Release and Announces Conference Call

MOUNTAIN VIEW, Calif., May 5, 2011 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) will release its first quarter 2011 financial results following the close of market on Monday, May 9, 2011. Dr. Clifford A. Reid, chairman, president, and CEO, and Ajay Bansal, CFO, will host a conference call at 2:00 p.m. PDT (5:00 p.m. EDT) to discuss the financial results for the first quarter.
/ Source: GlobeNewswire

MOUNTAIN VIEW, Calif., May 5, 2011 (GLOBE NEWSWIRE) -- Complete Genomics, Inc. (Nasdaq:GNOM) will release its first quarter 2011 financial results following the close of market on Monday, May 9, 2011. Dr. Clifford A. Reid, chairman, president, and CEO, and Ajay Bansal, CFO, will host a conference call at 2:00 p.m. PDT (5:00 p.m. EDT) to discuss the financial results for the first quarter.

Conference Call Details   

The conference dial in numbers are: 
US: (877) 844 - 6890   
International: (760) 298 - 5092   
Conference ID: 65709967

A live audio webcast of the call will be available in the Investor Relations section of the Complete Genomics website at . A replay of the conference call will also be available there approximately two hours after the call and for 30 days thereafter.

About Complete Genomics

Complete Genomics is a complete human genome sequencing company that has developed and commercialized an innovative DNA sequencing platform. The Complete Genomics Analysis Platform (CGA™ Platform) combines Complete Genomics' proprietary human genome sequencing technology with our advanced informatics and data management software. We offer this innovative, end-to-end, outsourced solution as CGA™ Service, and provide customers with data that is immediately ready to be used for genome-based research. Additional information can be found at .

The Complete Genomics logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=8216

CONTACT: Complete Genomics, Inc. Scott Sandler Investor Relations (650) 943-2788 ssandler@completegenomics.com